Evaluation of antiasthmatic activity of 7,8,9, 10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one in combination with ambroxol in Guinea pigs

Mukunda Bande, Kunal Nepali, Rohit Goyal, Vikas Thakur, Jyotsna Suri, Ramji Das Budhiraja, Om Parkash Suri, Preet Mohinder Singh Bedi, Kanaya Lal Dhar

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In the present study, the antiasthmatic activity of a 7,8,9,10-tetrahydro azepino[2,1-b]-quinazolin-12(6H)-one (TAZQ) and established mucolytic agent ambroxol, alone and in combination, in ovalbumin induced asthma in guinea pigs. TAZQ turned to be a potent bronchodilator when studied in in vitro tracheal strip preparation of sensitized guinea pigs against antigen induced contraction accompanied with notable antioxidant and anti-inflammatory activity at both 10 and 20 mg/kg doses. Ambroxol at the dose of 50 and 100 mg/kg found to possess potent antioxidant activity but devoid of any effect when studied for in vitro bronchodilatory or antigen induced bronchial hyper-responsiveness. The title compound in low dose combination with ambroxol significantly inhibited ovalbumin-induced airway hyper-responsiveness. The combination of two notably reduced eosinophilic infiltrations into lung and bronchoalveolar lavage fluid of sensitized animals signified the synergistic anti-inflammatory activity without any increase in bronchodilator activity of TAZQ. For relief in asthma attacks, presently studied bronchodilator mucolytic combination may be an effective treatment of choice that will take care of bronchoconstriction, bronchial inflammation, and restricted bronchial airflow due to mucus plugging into the bronchioles in acute and chronic asthma.

Original languageEnglish
Pages (from-to)4158-4167
Number of pages10
JournalMedicinal Chemistry Research
Volume21
Issue number12
DOIs
Publication statusPublished - Dec 1 2012
Externally publishedYes

Fingerprint

Ambroxol
Anti-Asthmatic Agents
Bronchodilator Agents
Expectorants
Guinea Pigs
Asthma
Ovalbumin
Bronchoalveolar Lavage Fluid
Respiratory Hypersensitivity
Anti-Inflammatory Agents
Antioxidants
Bronchioles
Antigens
Bronchoconstriction
Mucus
Infiltration
Animals
Inflammation
Fluids
7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one

Keywords

  • Airway hyper-responsiveness
  • Ambroxol
  • Asthma
  • Azepinoquinazoline
  • Ovalbumin

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry

Cite this

Evaluation of antiasthmatic activity of 7,8,9, 10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one in combination with ambroxol in Guinea pigs. / Bande, Mukunda; Nepali, Kunal; Goyal, Rohit; Thakur, Vikas; Suri, Jyotsna; Budhiraja, Ramji Das; Suri, Om Parkash; Singh Bedi, Preet Mohinder; Dhar, Kanaya Lal.

In: Medicinal Chemistry Research, Vol. 21, No. 12, 01.12.2012, p. 4158-4167.

Research output: Contribution to journalArticle

Bande, Mukunda ; Nepali, Kunal ; Goyal, Rohit ; Thakur, Vikas ; Suri, Jyotsna ; Budhiraja, Ramji Das ; Suri, Om Parkash ; Singh Bedi, Preet Mohinder ; Dhar, Kanaya Lal. / Evaluation of antiasthmatic activity of 7,8,9, 10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one in combination with ambroxol in Guinea pigs. In: Medicinal Chemistry Research. 2012 ; Vol. 21, No. 12. pp. 4158-4167.
@article{dc7e3ff6e715416b9933f2e3b954ee8f,
title = "Evaluation of antiasthmatic activity of 7,8,9, 10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one in combination with ambroxol in Guinea pigs",
abstract = "In the present study, the antiasthmatic activity of a 7,8,9,10-tetrahydro azepino[2,1-b]-quinazolin-12(6H)-one (TAZQ) and established mucolytic agent ambroxol, alone and in combination, in ovalbumin induced asthma in guinea pigs. TAZQ turned to be a potent bronchodilator when studied in in vitro tracheal strip preparation of sensitized guinea pigs against antigen induced contraction accompanied with notable antioxidant and anti-inflammatory activity at both 10 and 20 mg/kg doses. Ambroxol at the dose of 50 and 100 mg/kg found to possess potent antioxidant activity but devoid of any effect when studied for in vitro bronchodilatory or antigen induced bronchial hyper-responsiveness. The title compound in low dose combination with ambroxol significantly inhibited ovalbumin-induced airway hyper-responsiveness. The combination of two notably reduced eosinophilic infiltrations into lung and bronchoalveolar lavage fluid of sensitized animals signified the synergistic anti-inflammatory activity without any increase in bronchodilator activity of TAZQ. For relief in asthma attacks, presently studied bronchodilator mucolytic combination may be an effective treatment of choice that will take care of bronchoconstriction, bronchial inflammation, and restricted bronchial airflow due to mucus plugging into the bronchioles in acute and chronic asthma.",
keywords = "Airway hyper-responsiveness, Ambroxol, Asthma, Azepinoquinazoline, Ovalbumin",
author = "Mukunda Bande and Kunal Nepali and Rohit Goyal and Vikas Thakur and Jyotsna Suri and Budhiraja, {Ramji Das} and Suri, {Om Parkash} and {Singh Bedi}, {Preet Mohinder} and Dhar, {Kanaya Lal}",
year = "2012",
month = "12",
day = "1",
doi = "10.1007/s00044-011-9961-1",
language = "English",
volume = "21",
pages = "4158--4167",
journal = "Medicinal Chemistry Research",
issn = "1054-2523",
publisher = "Birkhause Boston",
number = "12",

}

TY - JOUR

T1 - Evaluation of antiasthmatic activity of 7,8,9, 10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one in combination with ambroxol in Guinea pigs

AU - Bande, Mukunda

AU - Nepali, Kunal

AU - Goyal, Rohit

AU - Thakur, Vikas

AU - Suri, Jyotsna

AU - Budhiraja, Ramji Das

AU - Suri, Om Parkash

AU - Singh Bedi, Preet Mohinder

AU - Dhar, Kanaya Lal

PY - 2012/12/1

Y1 - 2012/12/1

N2 - In the present study, the antiasthmatic activity of a 7,8,9,10-tetrahydro azepino[2,1-b]-quinazolin-12(6H)-one (TAZQ) and established mucolytic agent ambroxol, alone and in combination, in ovalbumin induced asthma in guinea pigs. TAZQ turned to be a potent bronchodilator when studied in in vitro tracheal strip preparation of sensitized guinea pigs against antigen induced contraction accompanied with notable antioxidant and anti-inflammatory activity at both 10 and 20 mg/kg doses. Ambroxol at the dose of 50 and 100 mg/kg found to possess potent antioxidant activity but devoid of any effect when studied for in vitro bronchodilatory or antigen induced bronchial hyper-responsiveness. The title compound in low dose combination with ambroxol significantly inhibited ovalbumin-induced airway hyper-responsiveness. The combination of two notably reduced eosinophilic infiltrations into lung and bronchoalveolar lavage fluid of sensitized animals signified the synergistic anti-inflammatory activity without any increase in bronchodilator activity of TAZQ. For relief in asthma attacks, presently studied bronchodilator mucolytic combination may be an effective treatment of choice that will take care of bronchoconstriction, bronchial inflammation, and restricted bronchial airflow due to mucus plugging into the bronchioles in acute and chronic asthma.

AB - In the present study, the antiasthmatic activity of a 7,8,9,10-tetrahydro azepino[2,1-b]-quinazolin-12(6H)-one (TAZQ) and established mucolytic agent ambroxol, alone and in combination, in ovalbumin induced asthma in guinea pigs. TAZQ turned to be a potent bronchodilator when studied in in vitro tracheal strip preparation of sensitized guinea pigs against antigen induced contraction accompanied with notable antioxidant and anti-inflammatory activity at both 10 and 20 mg/kg doses. Ambroxol at the dose of 50 and 100 mg/kg found to possess potent antioxidant activity but devoid of any effect when studied for in vitro bronchodilatory or antigen induced bronchial hyper-responsiveness. The title compound in low dose combination with ambroxol significantly inhibited ovalbumin-induced airway hyper-responsiveness. The combination of two notably reduced eosinophilic infiltrations into lung and bronchoalveolar lavage fluid of sensitized animals signified the synergistic anti-inflammatory activity without any increase in bronchodilator activity of TAZQ. For relief in asthma attacks, presently studied bronchodilator mucolytic combination may be an effective treatment of choice that will take care of bronchoconstriction, bronchial inflammation, and restricted bronchial airflow due to mucus plugging into the bronchioles in acute and chronic asthma.

KW - Airway hyper-responsiveness

KW - Ambroxol

KW - Asthma

KW - Azepinoquinazoline

KW - Ovalbumin

UR - http://www.scopus.com/inward/record.url?scp=84555218545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84555218545&partnerID=8YFLogxK

U2 - 10.1007/s00044-011-9961-1

DO - 10.1007/s00044-011-9961-1

M3 - Article

VL - 21

SP - 4158

EP - 4167

JO - Medicinal Chemistry Research

JF - Medicinal Chemistry Research

SN - 1054-2523

IS - 12

ER -